Targeting Survivin in cancer : novel drug development approaches

  • Survivin is a well-established target in experimental cancer therapy. The molecule is over-expressed in most human tumors, but hardly detectable in normal tissues. Multiple functions in different subcellular compartments have been assigned. It participates in the control of cell division, apoptosis, the cellular stress response, and also in the regulation of cell migration and metastasis. Survivin expression has been recognized as a biomarker: high expression indicates an unfavorable prognosis and resistance to chemotherapeutic agents and radiation treatment. Survivin is an unconventional drug target and several indirect approaches have been exploited to affect its function and the phenotype of survivin-expressing cells. Interference with the expression of the survivin gene, the utilization of its messenger RNA, the intracellular localization, the interaction with binding partners, the stability of the survivin protein, and the induction of survivin-specific immune responses have been taken into consideration. A direct strategy to inhibit survivin has been based on the identification of a specifically interacting peptide. This peptide can recognize survivin intracellularly and cause the degradation of the ligand–survivin complex. Technology is being developed that might allow the derivation of small molecular-weight, drug-like compounds that are functionally equivalent to the peptide ligand.

Download full text files

Export metadata

Additional Services

Share in Twitter Search Google Scholar
Metadaten
Author:Bernd GronerGND, Astrid WeißGND
URN:urn:nbn:de:hebis:30:3-345758
DOI:https://doi.org/10.1007/s40259-013-0058-x
ISSN:1179-190X
ISSN:1173-8804
Pubmed Id:https://pubmed.ncbi.nlm.nih.gov/23955284
Parent Title (English):BioDrugs
Publisher:Springer
Place of publication:Berlin [u.a.]
Document Type:Article
Language:English
Date of Publication (online):2014/02/28
Date of first Publication:2014/02/28
Publishing Institution:Universitätsbibliothek Johann Christian Senckenberg
Release Date:2014/10/23
Volume:28
Issue:1
Page Number:13
First Page:27
Last Page:39
Note:
Copyright © The Author(s) 2013 Open AccessThis article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.
HeBIS-PPN:366546007
Institutes:Medizin / Medizin
Angeschlossene und kooperierende Institutionen / Georg-Speyer-Haus
Dewey Decimal Classification:6 Technik, Medizin, angewandte Wissenschaften / 61 Medizin und Gesundheit / 610 Medizin und Gesundheit
Sammlungen:Universitätspublikationen
Licence (German):License LogoCreative Commons - Namensnennung-Nicht kommerziell 3.0